Advertisement
Screener

CRONOS GROUP INC. (CRON) Net Income (Loss) from Discontinued Operations Available to Common Shareholders, Basic

2.2 / 5 stars · 30/68 Roast Me

CRONOS GROUP INC. Net Income (Loss) from Discontinued Operations Available to Common Shareholders, Basic

CRONOS GROUP INC. (CRON) reported Net Income (Loss) from Discontinued Operations Available to Common Shareholders, Basic of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.

Financial Statements › Income Statement › Other Income

us-gaap:NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic · last filed 2026-02-26

  • CRONOS GROUP INC. net income (loss) from discontinued operations available to common shareholders, basic for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
  • CRONOS GROUP INC. net income (loss) from discontinued operations available to common shareholders, basic for the quarter ending 2024-09-30 was $0.00.
  • CRONOS GROUP INC. net income (loss) from discontinued operations available to common shareholders, basic for the quarter ending 2024-06-30 was $0.00.
  • CRONOS GROUP INC. net income (loss) from discontinued operations available to common shareholders, basic for the quarter ending 2024-03-31 was $0.00.
  • CRONOS GROUP INC. net income (loss) from discontinued operations available to common shareholders, basic for fiscal 2025 was $0.00.
  • CRONOS GROUP INC. net income (loss) from discontinued operations available to common shareholders, basic for fiscal 2024 was $0.00.
  • CRONOS GROUP INC. net income (loss) from discontinued operations available to common shareholders, basic for fiscal 2023 was -$4.11M.
  • CRONOS GROUP INC. net income (loss) from discontinued operations available to common shareholders, basic for fiscal 2022 was -$13.56M.
Period endNet Income (Loss) from Discontinued Operations Available to Common Shareholders, Basic 3 monthNet Income (Loss) from Discontinued Operations Available to Common Shareholders, Basic 3 month as first filedNet Income (Loss) from Discontinued Operations Available to Common Shareholders, Basic 6 monthNet Income (Loss) from Discontinued Operations Available to Common Shareholders, Basic 6 month as first filedNet Income (Loss) from Discontinued Operations Available to Common Shareholders, Basic 9 monthNet Income (Loss) from Discontinued Operations Available to Common Shareholders, Basic 9 month as first filedNet Income (Loss) from Discontinued Operations Available to Common Shareholders, Basic 12 monthNet Income (Loss) from Discontinued Operations Available to Common Shareholders, Basic 12 month as first filed
2025-12-31$0.00
10-K · filed 2026-02-26
2024-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$0.00
derived: sum of 2 quarters · filed 2026-02-26
$0.00
derived: sum of 3 quarters · filed 2026-02-26
$0.00
10-K · filed 2026-02-26
2024-09-30$0.00
10-Q · filed 2024-11-12
$0.00
derived: sum of 2 quarters · filed 2024-11-12
$0.00
10-Q · filed 2024-11-12
$124.00K
derived: sum of 4 quarters · filed 2026-02-26
2024-06-30$0.00
10-Q · filed 2024-08-08
$0.00
10-Q · filed 2024-08-08
$124.00K
derived: sum of 3 quarters · filed 2026-02-26
-$58.00K
derived: sum of 4 quarters · filed 2026-02-26
2024-03-31$0.00
10-Q · filed 2024-05-09
$124.00K
derived: sum of 2 quarters · filed 2026-02-26
-$58.00K
derived: sum of 3 quarters · filed 2026-02-26
-$2.89M
derived: sum of 4 quarters · filed 2026-02-26
2023-12-31$124.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
-$58.00K
derived: sum of 2 quarters · filed 2026-02-26
-$2.89M
derived: sum of 3 quarters · filed 2026-02-26
-$4.11M
10-K · filed 2026-02-26
2023-09-30-$182.00K
10-Q · filed 2024-11-12
-$3.02M
derived: sum of 2 quarters · filed 2024-11-12
-$4.24M
10-Q · filed 2024-11-12
-$6.91M
derived: sum of 4 quarters · filed 2025-02-27
2023-06-30-$2.83M
10-Q · filed 2024-08-08
-$4.06M
10-Q · filed 2024-08-08
-$6.73M
derived: sum of 3 quarters · filed 2025-02-27
-$10.51M
derived: sum of 4 quarters · filed 2025-02-27
2023-03-31-$1.22M
10-Q · filed 2024-05-09
-$3.90M
derived: sum of 2 quarters · filed 2025-02-27
-$7.68M
derived: sum of 3 quarters · filed 2025-02-27
-$10.49M
derived: sum of 4 quarters · filed 2025-02-27
2022-12-31-$2.68M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27
-$6.46M
derived: sum of 2 quarters · filed 2025-02-27
-$9.27M
derived: sum of 3 quarters · filed 2025-02-27
-$13.56M
10-K · filed 2025-02-27
$0.00
10-K · filed 2023-02-28
2022-09-30-$3.78M
10-Q · filed 2023-11-08
$0.00
10-Q · filed 2022-11-07
-$6.59M
derived: sum of 2 quarters · filed 2023-11-08
-$10.88M
10-Q · filed 2023-11-08
$0.00
10-Q · filed 2022-11-07
-$275.22M
derived: sum of 4 quarters · filed 2024-02-29
2022-06-30-$2.81M
10-Q · filed 2023-08-08
$0.00
10-Q · filed 2022-08-09
-$7.10M
10-Q · filed 2023-08-08
$0.00
10-Q · filed 2022-08-09
-$271.44M
derived: sum of 3 quarters · filed 2024-02-29
-$271.35M
derived: sum of 4 quarters · filed 2024-02-29
2022-03-31$0.00
10-Q · filed 2022-05-10
-$268.63M
derived: sum of 2 quarters · filed 2024-02-29
-$268.54M
derived: sum of 3 quarters · filed 2024-02-29
-$269.10M
derived: sum of 4 quarters · filed 2024-02-29
2021-12-31-$268.63M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29
-$268.54M
derived: sum of 2 quarters · filed 2024-02-29
-$269.10M
derived: sum of 3 quarters · filed 2024-02-29
-$269.13M
10-K · filed 2024-02-29
-$500.00K
10-K · filed 2022-03-01
2021-09-30$82.00K
10-Q · filed 2022-11-07
-$479.00K
derived: sum of 2 quarters · filed 2022-11-07
-$500.00K
10-Q · filed 2022-11-07
-$631.00K
derived: sum of 4 quarters · filed 2023-02-28
2021-06-30-$561.00K
10-Q · filed 2022-08-09
-$582.00K
10-Q · filed 2022-08-09
-$713.00K
derived: sum of 3 quarters · filed 2023-02-28
-$1.19M
derived: sum of 4 quarters · filed 2023-02-28
2021-03-31-$21.00K
10-Q · filed 2022-05-10
-$152.00K
derived: sum of 2 quarters · filed 2023-02-28
-$625.00K
derived: sum of 3 quarters · filed 2023-02-28
-$671.00K
derived: sum of 4 quarters · filed 2023-02-28
2020-12-31-$131.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28
-$604.00K
derived: sum of 2 quarters · filed 2023-02-28
-$650.00K
derived: sum of 3 quarters · filed 2023-02-28
-$650.00K
10-K · filed 2023-02-28
2020-09-30-$473.00K
10-Q · filed 2022-02-18
-$519.00K
derived: sum of 2 quarters · filed 2022-02-18
-$519.00K
10-Q · filed 2022-02-18
2020-06-30-$46.00K
10-Q/A · filed 2022-02-18
-$46.00K
10-Q/A · filed 2022-02-18
2019-12-31-$363.00K
10-K · filed 2022-03-01

Similar stocks

Stock NameCountryMarket CapPE Ratio
Tilray Brands, Inc. (TLRY)United States$0.554B-5.97
Canopy Growth Corp (CGC)$0.395B
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
Niagen Bioscience, Inc. (NAGE)United States$0.238B15.72
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
MANNATECH INC (MTEX)United States$0.014B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87